Trending Medical and health breaking news Anifrolumab (Saphnelo) Gets Green Light for Approval in EU

Trending Medical and well being breaking information Anifrolumab (Saphnelo) Will get Inexperienced Mild for Approval in EU

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended marketing authorization for anifrolumab (Saphnelo) as an add-on treatment for adults with moderate to severe, active autoantibody-positive systemic lupus erythematosus (SLE), despite standard therapy, according to an announcement on Dec. 16. Anifrolumab, a monoclonal antibody that binds to subunit 1 of the…